Ş. Kirazlı

S. Aksöyek, E. Atalar, F. Ozmen, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Bloodstream Thrombopoietin in Rheumatoid Arthritis with Thrombocytosis

Ş. Kirazlı, S. Kiraz, I. Ertenli, 2002, Clinical Rheumatology.

Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation

J. Karakaya, S. Aksu, M. Kekıllı, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The Plasma Levels of Prostanoids and Plasminogen Activator Inhibitor-1 in Primary and Secondary Thrombocytosis

Ş. Kirazlı, A. Kosar, N. Bavbek, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.

Ç. Turgan, Ş. Kirazlı, O. Ozcebe, 1993, Nephron.

Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis

Ş. Kirazlı, S. Kiraz, I. Ertenli, 2005, Rheumatology International.

Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia.

N. Sayınalp, Ş. Kirazlı, S. Kiraz, 1996, Acta haematologica.

Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Thrombomodulin levels in Behçet's disease with and without the factor V Leiden mutation

A. Oner, A. Gürgey, L. Mesci, 2005, Clinical Rheumatology.

Paget-Schroetter Syndrome Associated with FV:Q506 and Prothrombin 20210A

R. Doğan, A. Gürgey, N. Sayınalp, 1999, Angiology.

The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.

Y. Bayraktar, A. Gürgey, Ş. Kirazlı, 2000, Journal of clinical gastroenterology.

The Predictability of Factor V Leiden (FV:Q506) Gene Mutation via Clotting-Based Diagnosis of Activated Protein C Resistance

S. Aksu, A. Gürgey, N. Sayınalp, 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Activated protein C resistance in Behçet's disease

Ş. Kirazlı, A. Kosar, Y. Büyükaşık, 1998, Rheumatology International.

Role of protein C in childhood cerebrovascular occlusive accidents

B. Anlar, Ç. Altay, Ş. Kirazlı, 1989, European Journal of Pediatrics.

In vivo platelet and T-lymphocyte activities during pulmonary tuberculosis.

Ş. Kirazlı, O. Ozcebe, I. Haznedaroğlu, 1998, The European respiratory journal.

The Search for a Common Thrombophilic State During the Active State of Inflammatory Bowel Disease

D. Aksoy, G. Hasçelik, I. Haznedaroglu, 2006, Journal of clinical gastroenterology.

Serum beta 2-microglobulin reflects disease activity in Behçet's disease

Ş. Kirazlı, A. Kosar, N. Bavbek, 2002, Rheumatology International.

Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia

Ş. Kirazlı, K. Acar, R. Haznedar, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Serum thrombopoietin levels in haemodialysis patients: involvement of arteriovenous fistula.

B. Altun, M. Arıcı, Ç. Turgan, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytokines, Endothelium, and Adhesive Molecules in Pathologic Thrombopoiesis

I. Haznedaroglu, Ş. Kirazlı, A. Kosar, 2001, Clinical and applied thrombosis/hemostasis.

Evidence for the role of dialysis hypoxemia in the pathogenesis of hemodialysis-induced rise in tissue-type plasminogen activator.

Ç. Turgan, Ş. Kirazlı, O. Ozcebe, 1992, Thrombosis research.

Interleukin‐1 β and interleukin‐6 in clonal versus reactive thrombocytosis

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 1995 .

Platelet Factor 4, β-Thromboglobulin and Thrombospondin Levels in Type I Diabetes Mellitus Patients

Ş. Kirazlı, S. Dündar, M. Bayraktar, 1994 .

Platelet factor 4, beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients.

Ş. Kirazlı, S. Dündar, M. Bayraktar, 1994, The Journal of international medical research.

Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.

M. Arıcı, Ş. Kirazlı, S. Pay, 1998, Clinical and experimental rheumatology.

Antimicrobial activity of Ankaferd Blood Stopper® against nosocomial bacterial pathogens

G. Hasçelik, I. Haznedaroglu, Ş. Kirazlı, 2010 .

Activation of blood coagulation in patients with mitral stenosis and sinus rhythm.

S. Göksel, Ş. Kirazlı, N. Ileri, 1998, The American journal of cardiology.

Impaired haemostatic kinetics and endothelial function in Behçet's disease

Ş. Kirazlı, O. Özdemir, S. Dündar, 1996, Journal of internal medicine.

Haemostasic markers in amyloid vs non‐amyloid uraemic patients on maintenance haemodialysis

Ş. Kirazlı, S. Dündar, Ş. Çaǵlar, 1996 .

Selectin adhesion molecules in Behçet's disease

Ş. Kirazlı, A. Kosar, Ş. Haznedaroğlu, 2000, Annals of the rheumatic diseases.

Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura

Ş. Kirazlı, A. Kosar, Y. Buyukasik, 1998, Annals of Hematology.

P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.

M. Arıcı, Ş. Kirazlı, S. Kiraz, 1998, The Journal of rheumatology.

Effects of Extracorporeal Circulation on Thrombin-Antithrombin III and Prothrombin Fragment 1+2 Levels

I. Haznedaroglu, Ş. Kirazlı, I. Paşaoǧlu, 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hemostatic Markers and Renal Function after Cardiopulmonary Bypass

I. Haznedaroglu, Ş. Kirazlı, M. Ateş, 2001 .

Molecular Markers of Hemostatic Activation in Preeclampsia

Ş. Kirazlı, Ş. Haznedaroğlu, O. Gökmen, 1997 .

Coagulation and Fibrinolysis in Amyloid and Non-amyloid Hemodialysis Patients: Assessment of Local Hemostatic Kinetics Within Arteriovenous Fistulas

Ç. Turgan, Şali Çağlar, Ş. Kirazlı, 1996 .

ENHANCED TISSUE FACTOR PATHWAY INHIBITOR RESPONSE AS A DEFENSE MECHANISM AGAINST ONGOING LOCAL MICROVASCULAR EVENTS OF LEGG-CALVE-PERTHES DISEASE

D. Aksoy, M. Aksoy, I. Haznedaroglu, 2005, Pediatric hematology and oncology.

Global assessment of the coagulation status in type 2 diabetes mellitus using rotation thromboelastography

Ş. Kirazlı, Serafettin Kirazli, Alper Gürlek, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Ultrastructural and Morphological Analyses of the In Vitro and In Vivo Hemostatic Effects of Ankaferd Blood Stopper

B. Haznedaroglu, H. Bilgili, S. Walker, 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

In Vivo Hemostatic Effect of the Medicinal Plant Extract Ankaferd Blood Stopper in Rats Pretreated With Warfarin

I. Haznedaroglu, Ş. Kirazlı, A. Kosar, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hemostatic Efficacy of Ankaferd Blood Stopper® in a Swine Bleeding Model

S. Aksu, H. Bilgili, M. Kurt, 2009, Medical Principles and Practice.

Haemostatic Actions of the Folkloric Medicinal Plant Extract Ankaferd Blood Stopper®

Ş. Kirazlı, I. Haznedaroğlu, H. Goker, 2008, The Journal of international medical research.

Cytokines in Behçet's disease.

N. Sayınalp, Ş. Kirazlı, O. Ozcebe, 1996, The Journal of rheumatology.

Haematopoietic cytokines and increased megakaryocytic proliferation in chromosome 5q deletion.

Ş. Kirazlı, O. Ozcebe, S. Dündar, 1997, Acta haematologica.

Increased erythropoietin response to venesection in erythrocytosic renal transplant patients

O. Oymak, Ç. Turgan, Ş. Kirazlı, 2006, International Urology and Nephrology.

Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.

A. Oner, A. Gürgey, Ş. Kirazlı, 1999, Leukemia & lymphoma.

Thrombin activatable fibrinolysis inhibitor activity (TAFIa) levels in neonates with meconium-stained amniotic fluid

Ş. Kirazlı, T. Gursoy, Ş. Yiğit, 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model

I. Haznedaroglu, Ş. Kirazlı, A. Kosar, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Selectins in normal pregnancy, pre-eclampsia and missed abortus.

Ş. Kirazlı, A. Kosar, A. Altınbaş, 2001, Haematologia.

The effect of short course high dose methylprednisolon therapy on fibrinogen level in children with acute lymphoblastic leukemia. A preliminary study.

A. Gürgey, Ş. Kirazlı, S. Unal, 2004, Leukemia research.

Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state

N. Sayınalp, Ş. Kirazlı, D. Özatlı, 2001, Rheumatology International.

Decreased Protein Z Concentrations Complicating the Hypercoagulable State of Behqet's Disease

K. Aytemir, I. Haznedaroglu, Ş. Kirazlı, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.

S. Aksu, N. Sayınalp, Ş. Kirazlı, 2004, Clinical and laboratory haematology.

Thrombopoietin and mean platelet volume in coronary artery disease

Ş. Kirazlı, A. Kosar, M. Ileri, 2001, Clinical cardiology.

Statin Potentiates Human Platelet eNOS Activity without Enhancing eNOS mRNA and Protein Levels

M. Moskowitz, H. Ay, T. Dalkara, 2008, Cerebrovascular Diseases.

Plasma Thrombopoietin in Patients With Cavernous Transformation of the Portal Vein

Y. Bayraktar, N. Sayınalp, Ş. Kirazlı, 2002, International journal of hematology.

Synovial fluid cytokine levels in Behçet's disease.

Ş. Kirazlı, S. Kiraz, M. Erman, 2001, Clinical and experimental rheumatology.

Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease

N. Sayınalp, Ş. Kirazlı, A. Kosar, 1999, Rheumatology International.

Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease.

N. Sayınalp, Ş. Kirazlı, A. Kosar, 1999, Rheumatology international.

Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease

I. Haznedaroglu, Ş. Kirazlı, S. Kiraz, 2004, Rheumatology International.

Haemostasis, Thrombosis, and Endothelium in Behcet's Disease

I. Haznedaroglu, Ş. Kirazlı, A. Kosar, 1998, Acta Haematologica.

Circulating Thrombomodulin as a Clue of Endothelial Damage in Behçet’s Disease

Ş. Kirazlı, S. Dündar, O. Özdemir, 1996, Thrombosis and Haemostasis.

Circulating thrombomodulin as a molecular marker of endothelium damage in renal transplant recipients.

Ç. Turgan, N. Sayınalp, Ş. Kirazlı, 1996, Nephron.

Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis.

Ş. Kirazlı, I. Haznedaroğlu, H. Şimşek, 1997, The American journal of gastroenterology.

Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state

Ş. Kirazlı, S. Kiraz, M. Erman, 2001, Annals of the rheumatic diseases.

Increased soluble glycoprotein V concentration during the acute onset of unstable angina pectoris in association with chronic cigarette smoking

N. Ozer, E. Atalar, F. Ozmen, 2005, Platelets.

Plasma Thrombospondin in Immune Thrombocytopenic Purpura

N. Sayınalp, Ş. Kirazlı, A. Kosar, 2002, The Journal of international medical research.

The adhesion molecules of L-selectin and ICAM-1 in thrombocytosis and thrombocytopenia

Deniz Koksal, Salih Aksu, S. Aksu, 2010, Platelets.

Change in blood coagulation parameters after total body irradiation

Ş. Kirazlı, M. Cengiz, G. Yazici, 2008 .

Plasma fibronectin- and thrombospondin-adhesive molecules during acute attacks and attack-free periods of familial Mediterranean fever

Ş. Kirazlı, S. Kiraz, I. Ertenli, 2001, Rheumatology International.

Anti-neutrophil cytoplasmic antibodies in familial mediterranean fever

A. Kadayifci, Ş. Kirazlı, H. Şimşek, 1996, Clinical Rheumatology.

Safety and Efficacy of Ankaferd Blood Stopper in Dental Surgery

M. Kurt, I. Onal, I. Haznedaroglu, 2010 .

Effects of Soy Protein Diet on Endothelial Functions and Lipid Parameters

A. Oto, L. Tokgözoğlu, A. Yıldırır, 2001 .

Soy protein diet significantly improves endothelial function and lipid parameters

A. Oto, A. Yıldırır, I. Haznedaroglu, 2000, Clinical cardiology.

Blood collection in strong acidic citrate anticoagulant for the determination of urokinase-like plasminogen activator.

N. Sayınalp, Ş. Kirazlı, O. Ozcebe, 1995, Thrombosis research.

Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis?

Y. Bayraktar, Ş. Kirazlı, F. Balkancı, 2006, World journal of gastroenterology.

Acute Budd-Chiari Syndrome Associated with Activated Protein C Resistance During Intravenous Anticoagulant Treatment

S. Cekirge, Ş. Kirazlı, B. Yıldız, 1998 .

Extent of Coronary Atherosclerosis and Homocysteine Affect Endothelial Markers

A. Oto, L. Tokgozoglu, F. Ozmen, 2001, Angiology.

Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis.

S. Aksu, Y. Beyazit, N. Sayınalp, 2008, Journal of the National Medical Association.

Bone Marrow and Peripheral Blood C-kit Ligand Concentrations in Patients with Thrombocytosis and Thrombocytopenia

N. Sayınalp, Ş. Kirazlı, O. Ozcebe, 2003, Hematology.

Circulating thrombomodulin, thrombospondin, and fibronectin in acute myeloblastic leukemias.

Ş. Kirazlı, A. Kosar, O. Ozcebe, 1999, Haematologia.

The significance and distinct interactions of various growth factors in physiologic and pathologic megakaryocytopoiesis/thrombocytopoiesis.

Ş. Kirazlı, S. Dundar, I. Gullu, 1997, Australian and New Zealand journal of medicine.

Megakaryocytopoietic cytokines in autoimmune thrombocytopenic purpura

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 1995, American journal of hematology.

Soluble Thrombomodulin and Fibrinolysis in Behçet’s Disease

I. Haznedaroglu, N. Sayınalp, Ş. Kirazlı, 1996 .

The prethrombotic/hypercoagulable state of Behçet's disease: comment on the article by Golden et al.

Ş. Kirazlı, O. Ozcebe, Y. Büyükaşık, 1997, Arthritis and rheumatism.

C 08 Impaired F VIII:C release to intravenous 1-Deamino-8-D arginine vasopressin in Behçet's disease: a clue for endothelial dysfunction?

Ş. Kirazlı, O. Ozcebe, S. Dündar, 1993 .

The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers.

Ş. Kirazlı, O. Ozcebe, Y. Karaaslan, 1992, Thrombosis research.

Possible cytokine mechanism of increased megakaryocytic proliferation in 5q‐ syndrome

Ş. Kirazlı, S. Dündar, O. Özcebe, 1996, American journal of hematology.

Short-Term Hemostatic Safety of Strontium Ranelate Treatment in Elderly Women with Osteoporosis

I. Haznedaroglu, Ş. Kirazlı, M. Cankurtaran, 2007, The Annals of pharmacotherapy.

SOLUBLE P-SELECTIN IN PRIMARY SJÖGREN’S SYNDROME

I. Haznedaroglu, Ş. Kirazlı, S. Kiraz, 2005 .

Portal vein thrombosis in cirrhotics: related with anticardiolipin antibodies?

Y. Bayraktar, Ş. Kirazlı, B. Sivri, 2003, Hepato-gastroenterology.

Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis?

A. Oto, U. Kalyoncu, B. Altun, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increased systemic coagulation activity in patients with rheumatic mitral stenosis: assessment of the clinical and echocardiographic determinants.

Ş. Korkmaz, Ş. Kirazlı, O. Ozcebe, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension.

N. Ozer, S. Aksöyek, E. Atalar, 2002, Platelets.

Stenotrophomonas maltophilia infection of the central venous catheter and lysis of an old thrombosis in a post-bone marrow transplantation child: Implications in the fibrinolytic process

D. Gür, D. Uçkan, N. Sayınalp, 2007, Scandinavian journal of infectious diseases.

Pseudospontaneous Platelet Aggregation and Spuriously Elevated Blood Cell Counts in Cryoglobulinemia

I. Haznedaroglu, Ş. Kirazlı, S. Karaahmetoğlu, 1998 .

Increased erythropoietin levels in reactive thrombocytosis.

O. Balçik, Ş. Kirazlı, Y. Karaaslan, 2002, Haematologia.

Decrements in the Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Association with Orlistat Treatment in Obesity

Ş. Kirazlı, S. G. Oz, G. Guven, 2006, Clinical and applied thrombosis/hemostasis.

Thrombopoietin and thrombospondin in renal allograft recipients.

S. Ulusoy, B. Altun, M. Arıcı, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Serum Immunoglobulin E and Soluble CD23 in Patients with Graves' Disease

T. Erbas, N. Sayınalp, Ş. Kirazlı, 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes.

Bulent Sivri, N. Ozer, S. Aksöyek, 2006, Journal of the National Medical Association.

Thrombopoietic cytokines and platelet count in multiple myeloma

Ş. Kirazlı, Z. N. Özkurt, M. Yağcı, 2010, Platelets.

Plasminogen Activator Inhibitor-2 and Alpha-Fetoprotein in Various Liver Disease States

Ş. Kirazlı, B. Sivri, E. Özyilkan, 1992, Thrombosis and Haemostasis.

Interleukin-1, -6, and -8 levels in juvenile chronic arthritis

A. Bakkaloğlu, S. Ozen, O. Ozdemir, 1997, Clinical Rheumatology.